BIOREACTORS MARKET ANALYSIS
Market Regional Insights
North America is expected to hold dominant position in bioreactors market due to presence of major biopharmaceutical manufacturing companies. Biopharmaceutical companies such as Gilead Science, Inc., Amgen, and Biogen, Inc. in the U.S. actively conducts research on novel therapies for the treatment of various diseases. Research of therapies associated with oncology such as monoclonal antibodies require usage of bioreactors on small as well as large scale for production purposes. Furthermore, according to the National Centre for Biotechnology Information (NCBI), in 2014, 65.6% of the clinical scale manufacturers and around 42% of the commercial manufacturers used single-use bioreactors to improve their bioprocessing. Europe is expected to witness significant growth rate in the bioreactors market due to increasing usage of bioreactors in biopharmaceutical companies. According to the Organization for Economic Co-operation and Development (OECD), in 2015, around 1,700 biopharmaceutical companies, which utilize bioreactors, are from Europe.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
